Biophorum leadership

Catherine Wyatt

Drug Substance
Drug Substance is the place where the twin aims of delivering medicines to today’s patients and innovating for the future come together. Working with our members and external partners enables us to shape a collaborative program of work that satisfies these requirements: Solving problems to enable medicines to be delivered better, faster, cheaper, and at the right quality while harnessing the Industry's voice to shape the future with regulatory aligned good practices. I feel proud to be working with such a great team and believe that the power of collaboration will always enable the whole to be greater than the sum of its parts.
biophorum people catherine wyatt new 47

More about the Phorum

Biography

Catherine joined BioPhorum in 2020 to lead the Adoption of Inline Monitoring and Realtime Release program. She brought her 30 years of leadership experience and put into action the process of helping the team set a clear direction with her characteristic passion for bringing order.

Catherine spent her Industry career with GSK, delivering change and business improvement at a business unit scale in R&D, Manufacturing, and Commercial areas. Latterly her role as Chief of Staff for GSK’s Specialty Franchise business focused on complex program management: aligning senior stakeholders across the business to provide strategic governance for its diverse portfolio. Catherine believes that people are at the heart of any change and uses her coaching skills daily to bring a balance between improving the process and sustaining delivery through people.